Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1982 Jan;69(1):104–112. doi: 10.1172/JCI110420

Regulation of Episodic Growth Hormone Secretion by the Central Epinephrine System

STUDIES IN THE CHRONICALLY CANNULATED RAT

L Cass Terry 1,2, W R Crowley 1,2, M D Johnson 1,2
PMCID: PMC371173  PMID: 7054231

Abstract

Catecholamines are postulated to regulate growth hormone (GH) secretion by their influence on the release of two hypothalamic substances, somatostatin, which inhibits GH release, and GH-releasing factor, as yet unidentified. Extensive pharmacologic studies in man and animals indicate a stimulatory effect of central norepinephrine and dopamine on GH, but the function of epiphephrine (EPI) is uncertain. Furthermore, many of the agents used to study the role of catecholamines in GH regulation are not selective in that they affect adrenergic as well as nor-adrenergic and/or dopaminergic neurotransmission. In the present investigation, central nervous system (CNS) EPI biosynthesis was selectively interrupted with the specific norepinephrine N-methyltransferase inhibitors, SK & F 64139 (Smith, Kline & French Laboratories) and LY 78335, (Eli Lilly & Co. Research Laboratories) and the effects of central EPI depletion on episodic GH secretion in the chronically cannulated rat model were determined. Inhibition of CNS EPI synthesis with SK & F 64139 caused complete suppression of episodic GH secretion and concomitantly reduced the EPI level in the hypothalamus without affecting dopamine or norepinephrine. Administration of LY 78335 produced similar effects on pulsatile GH. Morphine-induced, but not clonidine-induced, GH release also was blocked by SK & F 64139. These results indicate that (a) the central EPI system has a major stimulatory function in episodic GH release, (b) morphine-induced GH release is mediated by the central EPI system, and (c) clonidine stimulates GH release by activation of postsynaptic α-adrenergic receptors. Drugs that affect CNS adrenergic systems have a potential role in the diagnosis and treatment of disorders of GH secretion.

Full text

PDF
104

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blackard W. G., Heidingsfelder S. A. Adrenergic receptor control mechanism for growth hormone secretion. J Clin Invest. 1968 Jun;47(6):1407–1414. doi: 10.1172/JCI105832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boyd A. E., 3rd, Lebovitz H. E., Pfeiffer J. B. Stimulation of human-growth-hormone secretion by L-dopa. N Engl J Med. 1970 Dec 24;283(26):1425–1429. doi: 10.1056/NEJM197012242832602. [DOI] [PubMed] [Google Scholar]
  3. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. 1973 Jan 5;179(4068):77–79. doi: 10.1126/science.179.4068.77. [DOI] [PubMed] [Google Scholar]
  4. Chambers J. W., Brown G. M. Neurotransmitter regulation of growth hormone and ACTH in the rhesus monkey: effects of biogenic amines. Endocrinology. 1976 Feb;98(2):420–428. doi: 10.1210/endo-98-2-420. [DOI] [PubMed] [Google Scholar]
  5. Chihara K., Arimura A., Coy D. H., Schally A. V. Studies on the interaction of endorphins, substance P. and endogenous somatostatin in growth hormone and prolactin release in rats. Endocrinology. 1978 Jan;102(1):281–290. doi: 10.1210/endo-102-1-281. [DOI] [PubMed] [Google Scholar]
  6. Crowley W. R., Terry L. C. Effects of an epinephrine synthesis inhibitor, SKF64139, on the secretion of luteinizing hormone in ovariectomized female rats. Brain Res. 1981 Jan 5;204(1):231–235. doi: 10.1016/0006-8993(81)90670-3. [DOI] [PubMed] [Google Scholar]
  7. Drew G. M. alpha 2-adrenoceptor-blocking action of the phenylethanolamine-N-methyltransferase inhibitor SKF 64139. J Pharm Pharmacol. 1981 Mar;33(3):187–188. doi: 10.1111/j.2042-7158.1981.tb13750.x. [DOI] [PubMed] [Google Scholar]
  8. Dubb J. W., Stote R. M., Alexander F., Intoccia A. P., Geczy M., Pendleton R. G. Studies with a PNMT inhibitor. Clin Pharmacol Ther. 1979 Jun;25(6):837–843. doi: 10.1002/cpt1979256837. [DOI] [PubMed] [Google Scholar]
  9. Dupont A., Cusan L., Garon M., Labrie F., Li C. H. Beta-endorphin: stimulation of growth hormone release in vivo. Proc Natl Acad Sci U S A. 1977 Jan;74(1):358–359. doi: 10.1073/pnas.74.1.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Durand D., Martin J. B., Brazeau P. Evidence for a role of alpha-adrenergic mechanisms in regulation of episodic growth hormone secretion in the rat. Endocrinology. 1977 Mar;100(3):722–728. doi: 10.1210/endo-100-3-722. [DOI] [PubMed] [Google Scholar]
  11. Fuller R. W., Perry K. W. Lowering of epinephrine concentration in rat brain by 2,3-dichloro-alpha-methyl-benzylamine, an inhibitor of norepinephrine N-methyltransferase. Biochem Pharmacol. 1977 Nov 1;26(21):2087–2090. doi: 10.1016/0006-2952(77)90024-7. [DOI] [PubMed] [Google Scholar]
  12. Fuxe K., Jonsson G., Bolme P., Andersson K., Agnati L. F., Goldstein M., Hökfelt T. Reduction of adrenaline turnover in cardiovascular areas of rat medulla oblongata by clonidine. Acta Physiol Scand. 1979 Oct;107(2):177–179. doi: 10.1111/j.1748-1716.1979.tb06459.x. [DOI] [PubMed] [Google Scholar]
  13. Imura H., Kato Y., Katakami H., Matsushita N. Effect of CNS peptides on hypothalamic regulation of pituitary secretion. Adv Biochem Psychopharmacol. 1981;28:557–570. [PubMed] [Google Scholar]
  14. Koenig J., Mayfield M. A., Coppings R. J., McCann S. M., Krulich L. Role of central nervous system neurotransmitters in mediating the effects of morphine on growth hormone- and prolactin-secretion in the rat. Brain Res. 1980 Sep 22;197(2):453–468. doi: 10.1016/0006-8993(80)91130-0. [DOI] [PubMed] [Google Scholar]
  15. Lal S., De la Vega C. E., Sourkes T. L., Friesen H. G. Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum. J Clin Endocrinol Metab. 1973 Nov;37(5):719–724. doi: 10.1210/jcem-37-5-719. [DOI] [PubMed] [Google Scholar]
  16. Lal S., Martin J. B., De la Vega C. E., Friesen H. G. Comparison of the effect of apomorphine and L-DOPA on serum growth hormone levels in normal men. Clin Endocrinol (Oxf) 1975 May;4(3):277–285. doi: 10.1111/j.1365-2265.1975.tb01535.x. [DOI] [PubMed] [Google Scholar]
  17. Lal S., Tolis G., Martin S. B., Brown G. M., Guyda H. Effect of clonidine on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone in the serum of normal men. J Clin Endocrinol Metab. 1975 Nov;41(5):827–832. doi: 10.1210/jcem-41-5-827. [DOI] [PubMed] [Google Scholar]
  18. Lovinger R., Holland J., Kaplan S., Grumbach M., Boryczka A. T., Shackelford R., Salmon J., Reid I. A., Ganong W. F. Pharmacological evidence for stimulation of growth hormone secretion by a central noradrenergic system in dogs. Neuroscience. 1976 Dec;1(6):443–450. doi: 10.1016/0306-4522(76)90094-4. [DOI] [PubMed] [Google Scholar]
  19. Martin J. B. Functions of central nervous system neurotransmitters in regulation of growth hormone secretion. Fed Proc. 1980 Sep;39(11):2902–2906. [PubMed] [Google Scholar]
  20. Martin J. B. Twenty third annual Bowditch Lecture. Brain mechanisms for integration of growth hormones secretion. Physiologist. 1979 Feb;22(1):23–29. [PubMed] [Google Scholar]
  21. Massara F., Strumia E. Increase in plasma growth hormone concentration in man after infusion of adrenaline-propranolol. J Endocrinol. 1970 May;47(1):95–100. doi: 10.1677/joe.0.0470095. [DOI] [PubMed] [Google Scholar]
  22. Meyer V., Knobil E. Growth hormone secretion in the unanesthetized rhesus monkey in response to noxious stimuli. Endocrinology. 1967 Jan;80(1):163–171. doi: 10.1210/endo-80-1-163. [DOI] [PubMed] [Google Scholar]
  23. Müller E. E., Dal Pra P., Pecile A. Influence of brain neurohumors injected into the lateral ventricle of the rat on growth hormone release. Endocrinology. 1968 Oct;83(4):893–896. doi: 10.1210/endo-83-4-893. [DOI] [PubMed] [Google Scholar]
  24. Müller E. E., Sawano S., Arimura A., Schally A. V. Blockade of release of growth hormone by brain norepinephrine depletors. Endocrinology. 1967 Mar;80(3):471–476. doi: 10.1210/endo-80-3-471. [DOI] [PubMed] [Google Scholar]
  25. Pendleton R. G., Gessner G., Weiner G., Jenkins B., Sawyer J., Bondinell W., Intoccia A. Studies on SK&F 29661, an organ-specific inhibitor of phenylethanolamine N-methyltransferase. J Pharmacol Exp Ther. 1979 Jan;208(1):24–30. [PubMed] [Google Scholar]
  26. Pendleton R. G., McCafferty J. P., Roesler J. M. The effects of PNMT inhibitors upon cardiovascular changes induced by hemorrhage in the rat. Eur J Pharmacol. 1980 Aug 22;66(1):1–10. doi: 10.1016/0014-2999(80)90289-7. [DOI] [PubMed] [Google Scholar]
  27. Peuler J. D., Johnson G. A. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci. 1977 Sep 1;21(5):625–636. doi: 10.1016/0024-3205(77)90070-4. [DOI] [PubMed] [Google Scholar]
  28. Quabbe H. J., Schilling E., Helge H. Pattern of growth hormone secretion during a 24-hour fast in normal adults. J Clin Endocrinol Metab. 1966 Oct;26(10):1173–1177. doi: 10.1210/jcem-26-10-1173. [DOI] [PubMed] [Google Scholar]
  29. ROTH J., GLICK S. M., YALOW R. S., BERSONSA Hypoglycemia: a potent stimulus to secretion of growth hormone. Science. 1963 May 31;140(3570):987–988. doi: 10.1126/science.140.3570.987. [DOI] [PubMed] [Google Scholar]
  30. Rivier C., Vale W., Ling N., Brown M., Guillemin R. Stimulation in vivo of the secretion of prolactin and growth hormone by beta-endorphin. Endocrinology. 1977 Jan;100(1):238–241. doi: 10.1210/endo-100-1-238. [DOI] [PubMed] [Google Scholar]
  31. Rodbard D. Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clin Chem. 1974 Oct;20(10):1255–1270. [PubMed] [Google Scholar]
  32. Sauter A. M., Lew J. Y., Baba Y., Goldstein M. Effect of phenylethanolamine N-methyltransferase and dopamine-beta-hydroxylase inhibition on epinephrine levels in the brain. Life Sci. 1977 Jul 15;21(2):261–266. doi: 10.1016/0024-3205(77)90310-1. [DOI] [PubMed] [Google Scholar]
  33. Schalch D. S. The influence of physical stress and exercise on growth hormone and insulin secretion in man. J Lab Clin Med. 1967 Feb;69(2):256–269. [PubMed] [Google Scholar]
  34. Schaub C., Bluet-Pajot M. T., Mounier F., Segalen A., Duhault J. Effects of noradrenergic agonists and antagonists on growth hormone secretion under gamma-hydroxybutyrate narco-analgesia in the rat. Psychoneuroendocrinology. 1980;5(2):139–146. doi: 10.1016/0306-4530(80)90016-5. [DOI] [PubMed] [Google Scholar]
  35. Sole M. J., Hussain M. N. A simple specific radioenzymatic assay for the simultaneous measurement of picogram quantities of norepinephrine, epinephrine, and dopamine and in plasma and tissues. Biochem Med. 1977 Dec;18(3):301–307. doi: 10.1016/0006-2944(77)90064-3. [DOI] [PubMed] [Google Scholar]
  36. Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol. 1977;77:1–124. doi: 10.1007/BFb0050157. [DOI] [PubMed] [Google Scholar]
  37. Takahashi Y., Kipnis D. M., Daughaday W. H. Growth hormone secretion during sleep. J Clin Invest. 1968 Sep;47(9):2079–2090. doi: 10.1172/JCI105893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Tannenbaum G. S., Martin J. B. Evidence for an endogenous ultradian rhythm governing growth hormone secretion in the rat. Endocrinology. 1976 Mar;98(3):562–570. doi: 10.1210/endo-98-3-562. [DOI] [PubMed] [Google Scholar]
  39. Terry L. C., Martin J. B. Evidence for alpha-adrenergic regulation of episodic growth hormone and prolactin secretion in the undisturbed male rat. Endocrinology. 1981 May;108(5):1869–1873. doi: 10.1210/endo-108-5-1869. [DOI] [PubMed] [Google Scholar]
  40. Terry L. C., Martin J. B. Hypothalamic-pituitary responses to intracranial self-stimulation in the rat. Brain Res. 1978 Nov 17;157(1):89–104. doi: 10.1016/0006-8993(78)90998-8. [DOI] [PubMed] [Google Scholar]
  41. Terry L. C., Saunders A., Audet J., Willoughby J. O., Brazeau P., Martin J. B. Physiologic secretion of growth hormone and prolactin in male and female rats. Clin Endocrinol (Oxf) 1977;6 (Suppl):19S–28S. doi: 10.1111/j.1365-2265.1977.tb03335.x. [DOI] [PubMed] [Google Scholar]
  42. Van Vugt D. A., Meites J. Influence of endogenous opiates on anterior pituitary function. Fed Proc. 1980 Jun;39(8):2533–2538. [PubMed] [Google Scholar]
  43. Willoughby J. O., Brazeau P., Martin J. B. Pulsatile growth hormone and prolactin: effects of (+) butaclamol, a dopamine receptor blocking agent. Endocrinology. 1977 Oct;101(4):1298–1303. doi: 10.1210/endo-101-4-1298. [DOI] [PubMed] [Google Scholar]
  44. von Graffenried B., del Pozo E., Roubicek J., Krebs E., Poldinger W., Burmeister P., Kerp L. Effects of the synthetic enkephalin analogue FK 33-824 in man. Nature. 1978 Apr 20;272(5655):729–730. doi: 10.1038/272729a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES